Abstract:AIM: To clone and characterize novel genes that might be involved in hepatocellular carcinoma. METHODS: An EST fragment differentially expressed between hepatocellular carcinoma (HCC) and its adjacent nontumorous liver tissues had been doned using suppression subtractive hybridization (SSH). With this approach, we identified a novel EST that consisted of 447bp. In order to gain its full-length cDNA fragment, two gene-specific primers were designed for 3′-rapid amplification of cDNA end RACE. One HCC cell line, HepG2, was maintained in the RPMI1640 media and recommended culture conditions. Total RNA was extracted from HepG2 by the SV Total RNA Isolation System (Promega). PACE reactions were prepared using the SMART™ RACE cDNA amplification kit (Clontech). Initial amplification was carried out with gene-specific primer 3′GSP2(5′-CGCATAGT ACCAGTATCGACAA AGG-3′), followed by nested PCR using gene-specific primer 3′NGSP2(5′-TCCACATTACGGACCCGACGGATT- 3′). These amplified cDNA fragments obtained from RACE were subcloned into the PMD18-T vector (TaKaRa) and sequenced by ABI PRISM377 DNA sequencer. Basic local aligment search tools were carried out using BLASTN and dbEST and nr database. Northern blot was applied to detect the expression of these cDNA fragments between HCC and its adjacent nontumorous liver tissues. A total of 3 liver specimens were collected from the Southwest Hospital of Chongqing in China. The final diagnosis of HCC was confirmed by histological examination. Total RNA was extracted from either HCC or its adjacent nontumorous liver tissues in the same way. These cDNA fragments were excised from the PMD18-T vector, purified and 32P-labeled as cDNA probes using the random primed labeling method. Northern blot was prepared by using the ExpressHyb™ hybridization solution (Clontech) according to the protocol provided by the manufacturer. Combination of Northern blot and virtual Northern (http://www.ncbi.nlm.nih.gov/SAGE) (series analysis of gene expression, SAGE), expression of these cDNA fragments in multiple carcinoma and normal tissues were analyzed. RESULTS: Five EST fragments (694 447-3, 724 447-3, 697 447-3, 711 447-3, 692 447-3) were cloned, including two EST fragments with ploy (A) tail (694 447-3, 724 447-3). Compared with ESTs in GeneBank, the two EST fragments with ploy (A) tail represented novel genes with a common sequence. Five EST fragments accession numbers in Genebank were CK730344, CK730345, CK730346, CK730347, CK730348, respectively. Northern blot revealed that 694 447-3, 724 447-3 presented higher expression in HCC than that in its adjacent nontumorous liver tissues. Virtual Northern blot (SAGE) revealed that 694 447-3, 724 447-3 presented higher expression in multiple cancers that contained in brain, colon, breast, lung and stomach than that in their normal tissues. CONCLUSION: Two novel human hepatocellular carcinoma-associated cDNA fragments are identified. RACE technique is a rapid and effective method for seeking for disease related genes in specific tissues.

Construction and Screening of Suppression Subtractive Hybridization Library of Human Primary Hepatocellular Carcinoma

Construction of a Subtracted Cdna Library of Differentially Expressed Genes in Human Normal Liver Tissue and Primary Hepatocellular Carcinoma Tissue

Screening and Analysis of Differentially Expressed Genes in Human Hepatocellular Carcinoma Using Suppression Subtractive Hybridization

Construction of differentially expres sed cDNA library in human hepat ocellular carcinoma apoptotic cells with suppression subtractive hybridization

Rapid cloning and expression of hepatocellular carcinoma associated cDNA fragments

Construction and Screening of Suppression Subtractive Hybridization Library of Renal Cell Carcinoma

Identification Of Genes Differentially Expressed In Human Hepatocellular Carcinoma By A Modified Suppression Subtractive Hybridization Method

Construction of a cDNA library of human hepatoma cells with apoptosis induced by adriamycin

Cdna Suppression Subtraction Library for Screening Down-Regulated Genes in Gastric Carcinoma

Screening of Differentially Expressed Genes in Human Renal Cell Carcinoma Using Suppression Subtractive Hybridization

Identification of differential expression of genes in hepatocellular carcinoma by suppression subtractive hybridization combined cDNA microarray.

Screening and cloning of target genes transactivated by human gene C1 encoding protein 1 interacting with HBV core antigen using suppression subtractive hybridization technique

Construction of cDNA library from hepatocellular carcinoma tissue and screening of antigenic genes

Screening and Cloning Up-Regulated Expressed Genes in Differential Liver Fibrosis by Suppression Subtractive Hybridization Technique

Cloning of Genes Transactivated by Hepatitis C Virus E2 Protein by Suppression Subtractive Hybridization Technique

Suppression Subtractive Hybridization for Screening of Upregulated Gene Expressions in Interferon-Alpha Transfected HepG2 Cell Line

Combination of Suppresion Subtractive Hybridization and Cdna Microarray for Identification of the Hepatic Stellate Cell Continual Activation Related Genes

Construction of A Metastasis-Associated Gene Subtracted Cdna Library of Human Colorectal Carcinoma by Suppression Subtraction Hybridization

[Molecular Cloning of Genes Differentially Expressed in Human Lung Squamous Cell Carcinoma Using Suppression Subtractive Hybridization].

Screening and Cloning of Genes Down-regulated in Hepatic Stellate Cells Treated with Glycyrrhizin Using Suppression Subtractive Hybridization Technique

Identification of hepatocellular carcinoma antigens by serological analysis of recombinant cDNA expression library and detection of hcct-19 expression in human tissues and cell lines